Home / Aenova Group - Location Regensburg, Germany /

Aenova Group - Location Regensburg, Germany

Competence Center high potent solids (oncology) conventional solids - specialty semisolids & liquids.

Germany Europe

Aenova Group - Location Regensburg, Germany

Competence Center high potent solids (oncology) conventional solids - specialty semisolids & liquids.

Aenova Group - Location Regensburg, Germany

About the plant

The Aenova Group site in Regensburg with its special environment is one of the leading HPAPI development, production and packaging facilities for high potent solids:

  • - Capsules, tablets and film coated tablets
  • - From small to large scale (0,5 to 500kg)
  • - Covering complete lifecyle from development to commercial supply for Capsules, Tablets & Film Coated Tablets

The Aenova site in Regensburg is a state-of-the-art facility paired with high flexibility.

Strategic expansions will enable the site´s production capacity to double within the next years. This strategic expansion took place in 2023 to enable the site‘s production capacity for HPAPI to double within the next years and to offer tailor-made/ plant-in-plant solutions for customers.

More information here: Aenova Group


Certifications
  • EMA (EU GMP)
  • FDA (cGMP)
  • ANVISA (Brazil B-GMP)
  • Roszdravnadzor (Russia GMP)
  • MFDS/KFDA (Republic of Korea GMP)
  • PMDA/MHLW (Japan GMP)
  • SFDA (Saudi Food & Drug Authority)
  • TITCK (Turkish Health Authorities)

Activity
  • Oral liquids and semisolids, Oral solids / OSD, Bottles, Tubes, Oral solutions, Oral suspensions, Oral emulsions, Oral gels, Tablets, Hard capsules, Granules / Pellets, Powders, FDF / DRUG PRODUCTS, COSMETICS, NUTRACEUTICALS, Spray, Others, Foam manufacturing

Features
  • Uses: Investigational, Commercial (Phase IV), Preclinical, Phase I, Phase II, Phase III, Human, Veterinary
  • Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 5 / HPAPI (PDE < 10 µg/day)
  • DEA: N/A
  • BSL:
  • Therapeutic areas: N/A
  • Markets: FDA (USA), EMA (EU), PMDA (Japan), ANVISA (Brazil), MFDS (South Korea), Russian Health Authorities, SFDA (Saudi Arabia), Turkish Health Authorities

Batch Size / Reactor
  • Small, Medium, Large

Services
  • Regulatory services, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging, Preformulation studies, R&D, Process development, Tech transfer, Scale-up, Analytical methods development, Primary packaging, Secondary packaging, Labeling, Serialization

Get in touch
Address: Donaustaufer Straße 378, Regensburg
Germany
Year: 1953
Other plants of this company
Contact the CDMO commercial and technical team directly

I have read and accept the Terms and Conditions and the Privacy Policy.

Contact us

If you have any questions or suggestions, click here. We will be happy to assist you.

Want to see all the information?

Unleash the full power of MAI CDMO

Register for free

53Biologics
FAES FARMA
Ascil
Mabion
ReigJofre
Cambrex